MedPath
TGA Approval

BIVALIRUDIN JUNO bivalirudin (as trifluoroacetate) 250mg Powder for Injection vial (226748)

226748

BIVALIRUDIN JUNO bivalirudin (as trifluoroacetate) 250mg Powder for Injection vial

Juno Pharmaceuticals Pty Ltd

July 24, 2015

Medicine

Medicine

Active

Registered

Active Ingredients

bivalirudin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.